amoxicillin

(redirected from Moxatag)
Also found in: Dictionary, Thesaurus.
Related to Moxatag: Dispermox

amoxicillin

 [ah-moks″ĭ-sil´in]
an antibiotic that is a penicillin analogue similar in action to ampicillin but more efficiently absorbed from the gastrointestinal tract and therefore requiring less frequent dosage and not as likely to cause diarrhea.

a·mox·i·cil·lin

(ă-mok'si-sil'in),
A semisynthetic penicillin antibiotic with an antimicrobial spectrum similar to that of ampicillin.

amoxicillin

/amox·i·cil·lin/ (ah-mok″sĭ-sil´in) a semisynthetic derivative of ampicillin effective against a broad spectrum of gram-positive and gram-negative bacteria.

amoxicillin

(ə-mŏk′sĭ-sĭl′ĭn)
n.
A semisynthetic penicillin, C16H19N3O5S, having an antibacterial spectrum of action similar to that of ampicillin.

amoxicillin

[əmok′səsil′in]
a beta-lactam semisynthetic oral penicillin antibiotic.
indication It is prescribed in the treatment of infections caused by a susceptible gram-negative or gram-positive bacteria.
contraindication Known hypersensitivity to any penicillin prohibits its use.
adverse effects Among the most serious adverse reactions are anaphylaxis, nausea, and diarrhea. Allergic reactions and rashes are common.

amoxicillin

Infectious disease A broad-spectrum semisynthetic penicillin with activity similar to that of ampicillin

amoxicillin

Amoxycillin, an AMPICILLIN-like penicillin antibiotic, effective in TYPHOID and many other infections. Brand names are Amoxil and Galenamox. Compounded with lansoprazol and clarithromycin it is marketed as Heliclear.

amoxicillin

penicillin antibiotic of similar action to ampicillin; usually administered as 250 mg by mouth every 8 hours (125 mg every 8 hours for a child) for soft-tissue infections

a·mox·i·cil·lin

(ă-mok'si-sil'in)
A semisynthetic penicillin antibiotic with an antimicrobial spectrum similar to that of ampicillin.

amoxicillin, amoxycillin

an aminopenicillin, similar in action to ampicillin and susceptible to β-lactamase, but more efficiently absorbed from the gastrointestinal tract and with a longer duration of action.

amoxicillin-clavulanic acid
addition of clavulanic acid widens the spectrum of activity and renders amoxicillin resistant to β-lactamase. A widely used antibiotic in dogs and cats.
References in periodicals archive ?
David Downey, Almac Pharma Services' vice president of commercial operations, said, "Almac is delighted to be working with MiddleBrook to produce sample packs in support of the Moxatag product launch.
Moxatag (extended-release amoxicillin) Tablets, 775mg, is a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three components: one immediate-release component and two delayed-release components.
In this randomized, double-blind, double-dummy, parallel-group, non-inferiority trial, 775-mg Moxatag tablets were administered once daily for 10 days, compared with a regimen of 250 mg penicillin administered 4 times daily (1 g total dose) for 10 days.
Treatment-related or probably treatment-related adverse events reported in a phase III trial of Moxatag included vulvovaginal mycotic infections, diarrhea, nausea, vomiting, abdominal pain, and headache.
Polsky has no temancial disclosure regarding Moxatag or MiddleBrook Pharmaceuticals.
Comment: Safety and efficacy are based on a clinical trial of 608 adult and adolescent patients aged 12 years and older treated with Moxatag 775 mg once daily for 10 days or penicillin VK 250 mg q.
Approved by the FDA in 2008, Moxatag is a penicillin-class antibacterial indicated for the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes (S.
United States-based Pragma Pharmaceuticals is planning to re-introduce Moxatag 775mg (amoxicillin extended-release tablets), the first and only once daily amoxicillin, it was reported yesterday.
Under this expanded IncreaseRx program, physicians who previously received Moxatag samples and information from MiddleBrook field sales representatives will be able to request samples and receive important product information electronically," states Dave Becker, MiddleBrook's acting president and chief executive officer.
Moxatag is the only once-daily amoxicillin approved by the Food and Drug Administration.
During the Bankruptcy Court supervised process, we remain committed to continuing to promote MOXATAG([R]) utilizing our third party partner's electronic promotion program and maintaining MOXATAG and KEFLEX([R]) product availability to our trade sales customers," said David Becker, MiddleBrook Executive Vice President and Chief Financial Officer, and Acting President and Chief Executive Officer.
M2 EQUITYBITES-August 19, 2014-Pragma Pharmaceuticals plans to re-launch Moxatag 775mg